Back to Hudson Bay Capital Management LP Hudson Bay Capital Management LP

CHRSCHRS
28 quarters

Position history for Hudson Bay Capital Management LPHudson Bay Capital Management LP's holdings in COHERUS ONCOLOGY INC

Yes. Hudson Bay Capital holds 1,693,000 shares of CHRS (Coherus Oncology), worth $2.4M, as of its Q2 2026 13F filing. It reduced the position by 11,980 shares (-0.7%) from Q1 2026. Hudson Bay Capital has held CHRS since Q4 2022, across 15 quarterly 13F filings.

Current Value

$2.4M

Current Shares

1.7M

Total Value Change

+$1.5M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.7M
-0.7%
$2.4M0.0%$1.40
0
2026-Q1
Increased
1.7M
+104.2%
$2.9M0.0%$1.69
42
2025-Q4
Increased
835,000
+3.1%
$1.2M0.0%$1.42
26
2025-Q3
Decreased
810,000
-3.0%
$1.3M0.0%$1.64
0
2025-Q2
Unchanged
835,000
0.0%
$610,6360.0%$0.73
0
2025-Q1
Unchanged
835,000
0.0%
$673,8450.0%$0.81
0
2024-Q4
Increased
835,000
+6.4%
$1.2M0.0%$1.38
27
2024-Q3
Unchanged
785,000
0.0%
$816,4000.0%$1.04
0
2024-Q2
Increased
785,000
+12.1%
$1.4M0.0%$1.73
28
2024-Q1
Increased
700,000
+19.7%
$1.7M0.0%$2.39
30
2023-Q4
Increased
585,000
+42.7%
$1.9M0.0%$3.33
35
2023-Q3
Decreased
410,000
-6.3%
$1.5M0.0%$3.74
0
2023-Q2
Increased
437,500
+191.7%
$1.9M0.0%$4.27
42
2023-Q1
Unchanged
150,000
0.0%
$1M0.0%$6.84
0
2022-Q4
New
150,000
-
$1.2M0.0%$7.92
35
2022-Q3
Exited
0
-100.0%
$00.0%$9.61
0
2022-Q2
New
155,000
-
$1.1M0.0%$7.24
35
2021-Q4
Exited
0
-100.0%
$00.0%$15.96
0
2021-Q3
Decreased
30,000
-64.7%
$482,0000.0%$16.07
0
2021-Q2
Decreased
85,000
-8.1%
$1.2M0.0%$13.83
0
2021-Q1
New
92,500
-
$1.4M0.0%$14.61
35
2020-Q4
Exited
0
-100.0%
$00.0%$17.38
0
2020-Q3
Decreased
45,000
-35.7%
$825,0000.0%$18.34
0
2020-Q2
Increased
70,000
+55.6%
$1.3M0.0%$17.86
36
2020-Q1
Increased
45,000
+11.6%
$730,0000.0%$16.22
27
2019-Q4
New
40,340
-
$726,0000.0%$18.01
34
2019-Q1
Exited
0
-100.0%
$00.0%$13.64
0
2018-Q4
First report
100,000
-
$905,0000.0%$9.05
0

Other major holders of CHRS: Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used